Literature DB >> 32533593

Perineural invasion in oral squamous cell carcinoma: Incidence, prognostic impact and molecular insight.

Huda Alkhadar1, Michaelina Macluskey1, Sharon White1, Ian Ellis2.   

Abstract

BACKGROUND: The objective of this study was to characterise the incidence and prognostic correlation of perineural invasion (PNI) in oral squamous cell carcinoma and determine whether nerve growth factor and its receptor tyrosine Kinase A expression could be used as biological markers for PNI.
METHODS: A retrospective review of pathology reports of 430 patients with oral squamous cell carcinoma who were treated from 1992 to 2014 in Tayside, Scotland, was carried out. The expression of nerve growth factor and tyrosine kinase A was assessed with immunohistochemistry in 132 tissue sections of oral squamous cell carcinoma.
RESULTS: Perineural invasion was identified in 17.4% of oral squamous cell carcinomas. High expression of nerve growth factor and tyrosine kinase A was seen in 84% and 92% of oral squamous cell carcinoma, respectively. Tumours with PNI expressed nerve growth factor and tyrosine kinase A with a greater frequency than tumours without PNI. PNI and high expression of nerve growth factor were significantly associated with pain. PNI was significantly associated with stage IV tumours and poor disease-specific survival.
CONCLUSIONS: A higher level of expression of nerve growth factor and tyrosine kinase A may predict PNI and therefore may be considered as biological markers for PNI in oral squamous cell carcinoma. PNI and nerve growth factor overexpression may contribute to the pain generation in oral cancer patients. PNI and nerve growth factor expression can predict the aggressiveness and prognosis of oral squamous cell carcinoma patients.
© 2020 The Authors. Journal of Oral Pathology & Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  nerve growth factor; oral squamous cell carcinoma; perineural invasion; tyrosine kinase A

Year:  2020        PMID: 32533593     DOI: 10.1111/jop.13069

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  A Distinctive Histological Form of Squamous Cell Carcinoma With Perineural Invasion.

Authors:  Jason T Bard; Stephan F Duran; Alice A Roberts; Joseph M Wentzell
Journal:  Cureus       Date:  2022-05-18

Review 2.  Receptor, Signal, Nucleus, Action: Signals That Pass through Akt on the Road to Head and Neck Cancer Cell Migration.

Authors:  Albashir Alzawi; Anem Iftikhar; Basher Shalgm; Sarah Jones; Ian Ellis; Mohammad Islam
Journal:  Cancers (Basel)       Date:  2022-05-25       Impact factor: 6.575

Review 3.  Molecular and Cellular Mechanisms of Perineural Invasion in Oral Squamous Cell Carcinoma: Potential Targets for Therapeutic Intervention.

Authors:  Carly I Misztal; Carlos Green; Christine Mei; Rita Bhatia; Jaylou M Velez Torres; Brandon Kamrava; Seo Moon; Elizabeth Nicolli; Donald Weed; Zoukaa Sargi; Christine T Dinh
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

4.  Is immunohistochemistry more sensitive than hematoxylin-eosin staining for identifying perineural or lymphovascular invasion in oral squamous cell carcinoma? A systematic review and meta-analysis.

Authors:  A-P Alves; D-S Paula; L-V Lima; T-S Dantas; M-R Mota; F-B Sousa; P-G Silva
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-05-01

5.  Long-Noncoding RNA MANCR is Associated With Head and Neck Squamous Cell Carcinoma Malignant Development and Immune Infiltration.

Authors:  Jianfei Tang; Mingyan Bao; Juan Chen; Xin Bin; Xinghuanyu Xu; Xiaodan Fang; Zhangui Tang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

Review 6.  Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis.

Authors:  Alessia Di Rito; Francesco Fiorica; Roberta Carbonara; Francesca Di Pressa; Federica Bertolini; Francesco Mannavola; Frank Lohr; Angela Sardaro; Elisa D'Angelo
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.